These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Deprescribing in older people. Page AT; Potter K; Clifford R; Etherton-Beer C Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift? Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893 [TBL] [Abstract][Full Text] [Related]
7. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy. McIntyre C; McQuillan R; Bell C; Battistella M Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. Komagamine J; Sugawara K; Hagane K BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778 [TBL] [Abstract][Full Text] [Related]
10. The Role of Patient Preferences in Deprescribing. Holmes HM; Todd A Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989 [TBL] [Abstract][Full Text] [Related]
11. Deprescribing Antihypertensive Medications in Older People: A Narrative Review, Part 1. Russell P; Thompson C; Mangoni AA Sr Care Pharm; 2023 Mar; 38(3):76-85. PubMed ID: 36803703 [TBL] [Abstract][Full Text] [Related]
12. Deprescribing for older adults in Australia: factors influencing GPs. Gillespie R; Mullan J; Harrison L Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283 [TBL] [Abstract][Full Text] [Related]
13. Community-dwelling older people's attitudes towards deprescribing in Canada. Sirois C; Ouellet N; Reeve E Res Social Adm Pharm; 2017; 13(4):864-870. PubMed ID: 27663392 [TBL] [Abstract][Full Text] [Related]
14. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing deprescribing habits among geriatricians. Ní Chróinín D; Ní Chróinín C; Beveridge A Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409 [TBL] [Abstract][Full Text] [Related]
16. Older patients' perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. Tegegn HG; Tefera YG; Erku DA; Haile KT; Abebe TB; Chekol F; Azanaw Y; Ayele AA BMJ Open; 2018 Apr; 8(4):e020590. PubMed ID: 29678983 [TBL] [Abstract][Full Text] [Related]
17. Are residents of aged care facilities willing to have their medications deprescribed? Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702 [TBL] [Abstract][Full Text] [Related]
18. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397 [TBL] [Abstract][Full Text] [Related]